 | Australia says looking forward to welcoming Indian students after Covishield approvalAustralia had imposed very strict travel restrictions on people travelling in and out of the country. |
 | Novavax asks WHO to grant emergency use approval to its COVID vaccineNovavax and its partner the Serum Institute say their request for the COVID-19 vaccine to the UN health agency is based on a previous submission to Indian regulators. |
 | Confusion reigns over Covishield on UK's travel advisory as India not on eligibility listSo far it means, under the new rules from October 4, Indian travellers must take a COVID test three days before departure and book in advance for two COVID tests to be taken upon arrival in England. |
 | SII to supply nearly 22 crore doses of Covishield vaccine to Centre in OctoberThe Pune-based pharmaceutical company has enhanced the manufacturing capacity of Covishield to more than 20 crore doses per month. |
 | SII to supply Inactivated Polio Vaccine to Centre for Universal Immunisation ProgrammeThe Union Health Ministry has recently placed a purchase order with SII for 54 lakh doses of IPV vaccine. |
| Centre places 66 crore Covishield doses order with SII to be supplied by December: SourcesSerum Institute of India has enhanced the manufacturing capacity of Covishield to more than 20 crore doses per month. |
| Serum Institute informs Centre it will supply around 20 crore Covishield doses in SeptemberIn a production plan submitted to the Centre in May, SII's director had communicated that the production of Covishield would be ramped up to 10 crore each in August and September, sources had said. |
| Fighting COVID: Centre allocates Rs 267.35 crore to Kerala, allows purchasing of 10 lakh Covishield dosesThe Centre had earlier allowed states and private hospitals to procure 50 per cent of the vaccines following demands for a decentralisation of the process. |
 | COVID vaccine export ban 'very bad' move; son warned not to speak against it: SII's Cyrus PoonawallaOver 150 countries are dependent on the SII for vaccines and are blaming the company for stopping the supply during a crucial period, Cyrus Poonawalla said. |
 | No need to mix two COVID jabs: Serum Institute chairman Poonawalla against using cocktail of vaccinesThe efficacy of this approach has not been proven in field trials involving thousands of participants, he said. |
 | Had to fall at bureaucrats' feet 50 years ago, but licence raj came down under Modi govt: PoonawallaLicence raj culture has diminished, which has resulted in quick launch of the coronavirus vaccine, Serum Institute of India chairman Cyrus Poonawalla said. |
 | Single-dose Johnson and Johnson vaccine gets Indian drug regulator nodJ&J has tied up with Hyderabad-based Biological E for the global supply chain network, hoping to supply its Covid-19 vaccine Janssen through extensive collaborations and partnerships. |
 | 78 crore doses of Covishield, Covaxin will be available between August and October: CentreIn August, nearly 25.5 crore doses of the two vaccines will be manufactured, while it will go to a little above 26 crore doses in September and 28 crore doses in October. |
 | Serum Institute CEO Adar Poonawalla sets aside Rs 10 crore to support students travelling abroadEarlier in July, he had lauded 16 European countries for recognising Covishield as an acceptable vaccine for entry. |
 | Serum Institute chairman Cyrus Poonawalla named as recipient of Lokmanya Tilak National AwardThe award ceremony will take place on August 13, he said, adding that the award comprises cash prize of Rs one lakh and a memento. |
